Garnet Health Medical Center
Middletown, New York, United States
Medical center in Orange County, New York
707 E Main St, Middletown, NY 10940
About Garnet Health Medical Center
Garnet Health Medical Center is a Middletown, New York-based three-campus hospital which, together with its nine urgent-care facilities, "provides care to approximately 450,000 residents in Orange, Sullivan and Ulster counties" in New York State. The hospital's roots date back to 1887.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
35
ECOG-ACRIN Cancer Research Group
2
NRG Oncology
2
Alliance for Clinical Trials in Oncology
1
Clinical Trials at Garnet Health Medical Center
During the past decade, Garnet Health Medical Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 20 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
2004-10-26
Active, not recruiting
452
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
2007-12-01
Active, not recruiting
427
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
2008-04-01
Active, not recruiting
525
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Garnet Health Medical Center"
#1 collaborator was "NRG Oncology" with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Garnet Health Medical Center
According to Clinical.Site data, the most researched conditions in "Garnet Health Medical Center" are
"Stage IIA Breast Cancer AJCC v6 and v7" (5 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (5 trials), "Stage IIIA Breast Cancer AJCC v7" (4 trials), "Recurrent Lung Non-Small Cell Carcinoma" (3 trials) and "Stage IB Breast Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Garnet Health Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Garnet Health Medical Center
Most popular intervention types in "Garnet Health Medical Center" are "Drug" (34 trials), "Other" (29 trials), "Biological" (25 trials), "Radiation" (11 trials) and "Procedure" (10 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Quality-of-Life Assessment" (11 trials), "Bevacizumab" (9 trials), "Carboplatin" (7 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.
Clinical Trials Genders at Garnet Health Medical Center
The vast majority of trials in "Garnet Health Medical Center" are
32 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Garnet Health Medical Center
Currently, there are NaN active trials in "Garnet Health Medical Center".
undefined are not yet recruiting,
6 are recruiting,
29 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Garnet Health Medical Center,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Garnet Health Medical Center, 0 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 28 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".